Drugs / CENSAVUDINE
last change Dec 2015 re-read 2 minutes ago

CENSAVUDINE

Small molecule

Developed for
HIV infectious disease
Investigated by
Bristol-Myers Squibb

Trials 1 · a red edge is where a trial was stopped

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01489046 Feb 2011 → Mar 2013 HIV infectious disease Bristol-Myers Squibb Terminated No outcome recorded

Evidence & citations 11 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as CENSAVUDINE ChEMBL registry synonym — accepted as the source's own label CHEMBL124363
Known as 4'-ed4t ChEMBL registry synonym — accepted as the source's own label CHEMBL124363
Known as 4'-ethynyl stavudine ChEMBL registry synonym — accepted as the source's own label CHEMBL124363
Known as BMS-986001 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01489046
Known as Censavudina ChEMBL registry synonym — accepted as the source's own label CHEMBL124363
Known as Censavudine, 4'-ethynyl-d4t ChEMBL registry synonym — accepted as the source's own label CHEMBL124363
Known as Festinavir ChEMBL registry synonym — accepted as the source's own label CHEMBL124363
Known as OBP-601 ChEMBL registry synonym — accepted as the source's own label CHEMBL124363
Action Inhibit “BMS-986001 is a thymidine analogue nucleoside reverse transcriptase inhibitor (NRTI)” PMID 26762988 Dec 2015
Modality Small molecule “BMS-986001 is a thymidine analogue nucleoside reverse transcriptase inhibitor (NRTI)” PMID 26762988 Dec 2015
Route Oral “Capsules, OralNCT01489046